[1]
|
Starek A, and Podolak (2009) Carcinogenic effect of to-bacco smoke Rocz Panstw Zakl Hig.;60(4):299-310.
|
[2]
|
Nazaroff, W.W., and Singer, B.C. (2004) Inhalation of hazardous air pollutants from environmental tobacco smoke in US residences J Expo Anal Environ Epidemiol.;14 Suppl 1:S71-7.
|
[3]
|
Heitzer, T. and Meinertz, T. (2000) Prevention of coronary heart disease: smoking. Z Kardiol.94 Suppl 3, III/30-42.
|
[4]
|
Ambrose, JA, and Barua, RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update J Am Coll Cardiol. 2004 May 19;43(10):1731-7.
|
[5]
|
Czernin, J., Sun, K., Brunken, R., et al. (1995) Effect of acute and long-term smoking on myocardial blood flow and flow reserve. Circulation Jun 15 91(12):2891-7.
|
[6]
|
Ip, J.H., Fuster, V., Badimon, L., et al. (1990) Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol. Jun 15(7):1667-87.
|
[7]
|
Poreba, R., Skoczynska, A., Derkacz, A (2004). Effect of tobacco smoking on endothekial function in patients with coronary arteriosclerosis. Pol Arch Med Wewn Jan 111(1): 27-36
|
[8]
|
Palombo, C., Lubrano, V., Sampietro, T (1999). Oxidative stress, F2-isoprostanes and endothelial dysfunction in hypercholesterolemia. Cardiovasc Res. Dec 44(3):474-6.
|
[9]
|
Banerjee, M., Kang, K.H., Morrow, J.D., et al. (1992). Effects of a novel prostaglandin, 8-epi-PGF2 alpha, in rabbit lung in situ. Am J Physiol. Sep 263(3 Pt 2): H660-3.
|
[10]
|
Wilson, S.H., Best, P.J., Lerman, L.O., et al. (1999). En-hanced coronary vasoconstriction to oxidative stress product, 8-epi-prostaglandinF2 alpha, in experimental hypercholesterolemia. Cardiovasc Res. Dec 44(3):601-7.
|
[11]
|
Morrow, J.D., Frei, B., Longmire, A.W. et al. (1995) Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med. May 4 332(18):1198-203.
|
[12]
|
Yura, T., Fukunaga, M., Khan, R et al. (1999) Free-radical-generated F2-isoprostane stimulates cell proliferation and endothelin-1 expression on endothelial cells. Kidney Int. Aug 56(2):471-8.
|
[13]
|
Fukunaga, M., Yura, T., Badr, K.F. (1995) Stimulatory effect of 8-Epi-PGF2 alpha, an F2-isoprostane, on endothelin-1 release. J Cardiovasc Pharmacol., 26 Suppl 3:S51-2.
|
[14]
|
Friedewald, W.T., Levy, R.I., Fredrickson, D.S (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin ChemJun 18(6): 499-502.
|
[15]
|
Alberti, A., Bolognini, L., Macciantelli, D., et al. (2000) The radical cation of N,N-diethyl-para-phenylendiamine: a possible indicator of oxidative stress in biological samples. Res Chem intermed; 26: 253-67
|
[16]
|
Lubrano, V., Vassalle, C., L’Abbate, A., et al.. A new method to evaluate oxidative stress in humans. Immuno analyse & Biologie Spécialisée 2002, June 17 (3) : 172-175
|
[17]
|
De Sutter, J., De Buyzere, M., Gheeraert, P., et al. (2001) Fibrogen and C-reactive protein on admission as markers of final infart size after primary angioplasty for acute myocardial infarctio. Atherosclerosis ; 157: 189-196
|
[18]
|
Buffon, A., Liuzzo, G., Biasucci, M.L., et al. (1999) A Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary an-gioplasty. JACC June 28;34(5):1512-21
|
[19]
|
Hoidal, J.R. and Niewoehner, D.E. (1983) Pathogenesis of emphysema. Chest; 83: 679-685.
|
[20]
|
Kannel, W.B. (1981) Update on the role of cigarette smoking in coronary artery disease. Am Heart J; 101:319-328
|
[21]
|
Church, D.F. and Pryor, W.A. (1985) Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 64:111-126.
|
[22]
|
Prieme, H., Loft, S., Klarlund, M., et al. (1998) Effect of smoking cessation on oxidative DNA modification esti-mated by 8-oxo-7,8-dihydro-2'-deoxyguanosine excretion Carcinogenesis. Feb 19(2):347-51.
|
[23]
|
Yokode, M., Kita, T., Arai, H., et al Cholesteryl ester accumulation in macrophages incubated with low density lipoprotein pretreated with cigarette smoke extract. Proc Natl Acad Sci U S A 1988; 85:2344-2348
|
[24]
|
Frei, B., Forte, T.M., Ames, B.N., et al. (1991) Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma: protective effects of ascorbic acid. Biochem; 277:133-138
|
[25]
|
Schectman, G., Byrd, J.C., Gruchow, H.W. (1989) The influence of smoking on vitamin C status in adults. Am J Public Health; 79:158-162.
|
[26]
|
Rimm, E.B., Stampfer, M.J., Ascherio, A., et al. (1993) Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med; 328:1450-1456
|
[27]
|
Singh, R.B., Niazma, Bishnol, Z., et al. (1994) Diet anti-oxidant vitamins, oxidative stress and risk of coronary artery disease: the Peerzada Prospective Study. Acta Car-diol. 49: 453-497
|
[28]
|
Morrow, J., Frei, B., Longmire, A., et al. (1995) Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med. 332:1198–1203.
|
[29]
|
Penn, A. and Snyder, C.A. (1993) Inhalation of sidestream cigarette smoke accelerates development of arteriosclerotic plaques. Circulation.88:1820–1825.
|
[30]
|
Knight-Lozano, C.A., Young, C.G., Burow D.L., et al. (2002) Cigarette smoke exposure and hypercholesterole-mia increase mitochondrial damage in cardiovascular tis-sues. Circulation. 105: 849–854.
|
[31]
|
Ramos, K.S., Zhang, Y., Sadhu, D.N., et al. (1996) The induction of proliferative vascular smooth muscle cell phenotypes by benzo(a)pyrene is characterized by up-regulation of inositol phospholipid metabolism and c-Ha-ras gene expression. Arch Biochem Biophys. ; 332:213–222.
|
[32]
|
Ou, X., and Ramos K.S. Proliferative responses of quail aortic smooth muscle cells to benzo[a]pyrene: implications in PAH-induced atherogenesis. Toxicology 1992 ; 74:243–258.
|
[33]
|
Lubrano, V., Cocci, F., Battaglia, D., et al. (2005) Use-fulness of high-sensitivity IL-6 measurement for clinical characterization of patients with coronary artery disease J Clin Lab Anal.; 19(3):110-4.
|